Precidiag, Inc
Steven A. Kates, Ph.D. is a world-leading chemist and industry expert in peptide design and manufacture. He has advanced several compounds through drug development from early pre-clinical to early clinical development.
Dr. Kates currently serves as Vice President, Regulatory Affairs at Synlogic Therapeutics. He has held senior positions at Takeda, Lakewood-Amedex, Ischemix, Citius Pharmaceuticals, Surface Logix, Consensus, and Millipore Corporation.
He has written or co-authored more than 100 articles, reviews, and patents. Dr. Kates lectures on Drug Development at Northeastern University. He is a Visiting Professor of Chemistry at Brandeis University.
This person is not in the org chart
This person is not in any offices
Precidiag, Inc
Precision Medicine - Leveraging the Gut Microbiome’s Role in Human Health to Develop Precision Therapeutics